Amphastar Jumps on FDA Approval of Generic Hypoglycemia Injection

Daily Updates


Shares of microcap pharmaceutical company Amphastar Pharmaceuticals  (AMPH) – Get Report rose sharply Tuesday after the company said its glucagon injection emergency kit has been approved by the FDA for the abbreviated new-drug application (ANDA) required for generic drugs.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *